TSN the sustainable nutrition group ltd

risk analysis, page-5

  1. 483 Posts.
    lightbulb Created with Sketch. 60
    I wouldn't go that far. Single product, dependant on a foreign partner. What if DRL run into similar issues to Ranbaxy? Sure ACL isn't as speculative as it once was, but its still specco.

    Having said that, I think we in for some seriously good wealth creation, but I don't have a dollar in here that I can't burn.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.